🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Canada / NCT05822791
Active, not recruiting Observational

Differences in ECG- vs. proLonged cardIac MonItor-DeTected Atrial Fibrillation in STROKE Patients (DELIMIT AF-STROKE)

NCT05822791 · tracked via the Priya Life Science Canada tracker
Phase
Observational
Started
2023-05-01
Last updated
2026-09-18

Condition(s) studied

StrokeAtrial FibrillationTIA

Investigational drug(s) / intervention(s)

Prolonged cardiac monitoringECG

Prolonged cardiac monitoring: Prolonged cardiac monitoring

ECG: Electrocardiogram

Study summary

The present study is an investigator-initiated, single-center, retrospective study based on data from the London Ontario Stroke Registry (LOSR), aiming to compare the characteristics and outcomes of ECG-detected and Device-Detected atrial fibrillation in patients with ischemic stroke and transient ischemic attack.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age ≥18 years * Patient with a diagnosis of ischemic stroke or TIA. * ECG-diagnosed AF or PCM-detected AF post ischemic stroke or TIA Exclusion Criteria: * Individuals younger than18 years-old * Patients without IS or TIA diagnosis

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Heart & Brain Lab, Western University London Ontario

More Luciano A. Sposato trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05822791 on ClinicalTrials.gov ↗ ← All trials in Canada